Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Results 101-120 of 138 (Search time: 0.017 seconds).

Issue DateTitleAuthor(s)
1012009Repression of NHE1 expression by PPARγ activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivoKumar, A.P. ; Quake, A.L. ; Zhou, T.; Pervaiz, S. ; Chang, M.K.X. ; Clement, M.-V. ; Lim, K.S.Y. ; Hewitt, R.E. ; Salto-Tellez, M. ; Singh, R. 
1024-Mar-2021Review micrornas as modulators of oral tumorigenesis—a focused reviewRishabh, Kumar; Khadilkar, Soham; Kumar, Aviral; Kalra, Ishu; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.
103Aug-2020Role of microRNA/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancerAshrafizadeh, M.; Hushmandi, K.; Hashemi, M.; Akbari, M.E.; Kubatka, P.; Raei, M.; Koklesova, L.; Shahinozzaman, M.; Mohammadinejad, R.; Najafi, M.; Sethi, G. ; Kumar, A.P. ; Zarrabi, A.
1042013Role of NF-κB in tumorigenesisShanmugam, M.K. ; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
1052018Role of novel histone modifications in cancerShanmugam, M.K ; Arfuso, F; Arumugam, S; Chinnathambi, A; Jinsong, B ; Warrier, S; Wang, L.Z ; Kumar, A.P ; Ahn, K.S; Sethi, G ; Lakshmanan, M
106Dec-2013Secreted frizzled related proteins: Implications in cancersSurana, R.; Sikka, S.; Cai, W.; Shin, E.M.; Warrier, S.R.; Tan, H.J.G.; Arfuso, F.; Fox, S.A.; Dharmarajan, A.M.; Kumar, A.P. 
1072017Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cellsThirunavukkarasan M.; Wang C. ; Rao A. ; Hind T.; Teo Y.R.; Siddiquee A.A.-M. ; Goghari M.A.I.; Kumar A.P. ; Herr D.R. 
1082014Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene productsManu, K.A.; Shanmugam, M.K. ; Li, F.; Chen, L.; Siveen, K.S.; Ahn, K.S.; Kumar, A.P. ; Sethi, G.
10918-Feb-2021Small in size, but large in action: Micrornas as potential modulators of pten in breast and lung cancersAbadi, Asal Jalal; Zarrabi, Ali; Gholami, Mohammad Hossein; Mirzaei, Sepideh; Hashemi, Farid; Zabolian, Amirhossein; Entezari, Maliheh; Hushmandi, Kiavash; Ashrafizadeh, Milad; Khan, Haroon; Kumar, Alan Prem 
11016-Mar-2021Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systemsMirzaei, Sepideh; Mahabady, Mahmood Khaksary; Zabolian, Amirhossein; Abbaspour, Alireza; Fallahzadeh, Peyman; Noori, Maedeh; Hashemi, Farid; Hushmandi, Kiavash; Daneshi, Salman; Kumar, Alan Prem ; Aref, Amir Reza; Samarghandian, Saeed; Makvandi, Pooyan; Khan, Haroon; Hamblin, Michael R; Ashrafizadeh, Milad; Zarrabi, Ali
11130-Mar-2021Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell linesHosoi, Hiroki ; Niibori-Nambu, Akiko; Nah, Giselle Sek Suan; Bahirvani, Avinash Govind ; Mok, Michelle Meng Huang ; Sanda, Takaomi ; Kumar, Alan Prem ; Tenen, Daniel G ; Ito, Yoshiaki; Sonoki, Takashi; Osato, Motomi 
11215-Mar-2011Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivoRajendran, P.; Ong, T.H.; Chen, L.; Li, F.; Shanmugam, M.K. ; Vali, S.; Abbasi, T.; Kapoor, S.; Sharma, A.; Kumar, A.P. ; Hui, K.M.; Sethi, G.
1132014Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-γBharathkumar, H; Paricharak, S; Dinesh, K.R; Siveen, K.S ; Fuchs, J.E; Rangappa, S; Mohan, C.D; Mohandas, N ; Kumar, A.P ; Sethi, G ; Bender, A; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Palace Road, Bangalore, 560001, India; Rangappa, K.S
1141-Dec-2013Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerShrimali, D.; Shanmugam, M.K. ; Kumar, A.P. ; Zhang, J.; Tan, B.K.H.; Ahn, K.S.; Sethi, G.
11528-Jul-2012Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancerShanmugam, M.K. ; Nguyen, A.H.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
1161-Dec-2022Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseAshrafizadeh, M; Paskeh, MDA; Mirzaei, S; Gholami, MH; Zarrabi, A; Hashemi, F; Hushmandi, K; Hashemi, M; Nabavi, N; Crea, F; Ren, J; Klionsky, DJ; Kumar, AP ; Wang, Y
11715-Apr-2019Targeting autophagy using natural compounds for cancer prevention and therapyDeng, Shuo ; Shanmugam, Muthu K ; Kumar, Alan Prem ; Yap, Celestial T ; Sethi, Gautam ; Bishayee, Anupam
1181-May-2022Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic ProspectsGangwar, Shailendra Kumar; Kumar, Aviral; Yap, Kenneth Chun-Hong ; Jose, Sandra; Parama, Dey; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
1192012Targeting PPAR γ signaling cascade for the prevention and treatment of prostate cancerSikka, S.; Chen, L.; Sethi, G.; Kumar, A.P. 
120Apr-2014Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitorsSikka, S.; Surana, R.; Dai, X.; Zhang, J.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.